Summary
The influence of concomitant administration of isoniazid (INH) on the acetylation of sulphadimidine has been studied in 6 healthy volunteers, previously identified as having the fast acetylator phenotype. INH was administered in a slow release form (500 mg tablet) 1 hour before the sulphadimidine. Acetylation of sulphadimidine was measured in plasma 6 h after its intake and in urine collected between 5 and 6 hours. INH significantly decreased the acetylated fraction of sulphadimidine in plasma from 69.0 to 54.0 and in urine from 85.9 to 81.2%. This was reflected in a significantly higher plasma concentration of unconjugated sulphadimidine and reduced urinary excretion of acetylated sulphadimidine. It is concluded that concomitant administration of INH inhibits acetylation of sulphadimidine. Fast acetylators at the border line of discrimination, may be misclassified if phenotyped with sulphadimidine during concomitant administration of INH.
Similar content being viewed by others
References
Evans DAP, Manley KA, McKumick VA (1960) Genetic control of isoniazid metabolism in man. Br Med J 2: 485–491
Clark DWJ (1985) Genetically determined variability in acetylation and oxidation. Therapeutic implications. Drugs 29: 342–375
Dubbels R, Kattner E, Sell-Maurer D, Schloot W (1980) Sulfadimidine and isoniazid loading in man and laboratory rats. Arzneimittelforsch/Drug Res 30 (II): 1574–1579
Evans DAP (1969) An improved and simplified method of detecting the acetylator phenotype. J Med Genet 6: 405–407
Bratton AC, Marshall EK Jr (1939) A new coupling component for sulphanilamide determination. J Biol Chem 128: 537
Timbrell JA, Wright JM, Smith CM (1977) Determination of hydrazine metabolites of isoniazid in human urine by gas chromatography. J Chromatogr 138: 165–172
Du Souich P, McLean AJ, Stoeckel K, Ohlendorf D, Gibaldi M (1979) Screening methods using sulfamethazine for determining acetylator phenotype. Clin Pharmacol Ther 26: 757–765
Talseth T, Landmark KH (1977) Polymorphic acetylation of sulphadimidine in normal and uraemic man. Eur J Clin Pharmacol 11: 33–36
Du Souich P, Lalka D, Slaughter R, Elvin AT, McLean AJ (1979) Mechanisms of nonlinear disposition kinetics of sulfamethazine. Clin Pharmacol Ther 25: 172–183
Platzer R, Küpfer A, Bircher J, Preisig R (1978) Polymorphic acetylation and aminopyrine demthylation in Gilbert's syndrome. Eur J Clin Invest 8: 219–223
Glatthaar E, Gärtig D, Stander MF, Kleeberg HH (1977) Isoniazid levels in black patients dosed with a matrix preparation (tebesium). Prax Pneumol 31: 885–889
Ylitalo P, Auterinen L, Marttinen A, Koivula T (1984) Acetylator phenotyping with sulphadimidine in patients receiving isoniazid. Int J Clin Pharmacol Res IV: 141–144
Gilman AG, Goodman LS, Gilman A (ed) (1980) The pharmacological basis of therapeutics, 6th ed. Macmillan, New York Toronto London
Tiitinen H (1969) Isoniazid and ethionamide serum levels and inactivation in Finnish subjects. Scand J Respir Dis 50: 110–124
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Zysset, T., Peretti, E. Effect of concomitant isoniazid administration on determination of acetylator phenotype by sulphadimidine. Eur J Clin Pharmacol 30, 463–466 (1986). https://doi.org/10.1007/BF00607961
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00607961